Clinical trial

A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

NCT00356421

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-11-01

PhasePHASE4

Study timeline

Study start (unknown)2006-11-01Date precision: month

Registry last updated2009-09-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

Inhaled Human Insulin (Exubera®)DRUG

Insulin lispro (Humalog)DRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

ViennaAustria2 StockholmSweden2 StrasbourgFrance1 LeuvenBelgium1 AmsterdamNetherlands1 LisbonPortugal1 New BrunswickNew Jersey, United States1 BrestFrance1 EdegemBelgium1 AarhusDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00356421 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.